NASDAQ: TSRO       Tesaro Inc
Last Price Today's Change   Day's Range   Trading Volume
61.01   -1.15 (1.85%)  58.07 - 64.26  854,602


Avg Volume (4 weeks):1,270,789
4 Weeks Range:52.20 - 70.70
4 Weeks Price Volatility (%):
52 Weeks Range:52.20 - 168.92
52 Weeks Price Volatility (%):
Average Price Target: 70.00
Price Target Upside/Downside: +8.99


No recent Headlines for this stock.

Business Background

TESARO, Inc. is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform. Rolapitant is a potent and long-acting neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Niraparib is an orally active and potent poly (adenosine diphosphate (ADP)-ribose) polymerase inhibitor. It has various ongoing clinical trials evaluating niraparib for the treatment of ovarian or breast cancers. It has initiated a Phase I, dose escalation study for its first immuno-oncology antibody, TSR-042, which targets Programmed cell death protein 1. It has commenced pre-clinical research for its antibody candidate targeting Lymphocyte-activation gene-3 andTSR-033. It has commenced a Phase I clinical trial of TSR-042.

  Be the first to like this.


1907  5559  510  585 

Top 10 Active Counters
 SPY 263.67-6.76 
 BAC 30.55-1.32 
 EEM 47.86-1.65 
 WFT 2.39-0.07 
 TVIX 9.52+1.90 
 XLF 27.66-1.06 
 NVCN 0.114+0.008 
 UVXY 18.68+3.09 
 FB 164.89-4.50 
 GE 13.35-0.53 
Partners & Brokers